title: Enhanced expression of mRNAs of antisecretory factor-1, gp96, DAD1 and CDC34 in human hepatocellular carcinomas.
abstract: To identify differentially expressed genes in hepatocarcinogenesis, we performed differential display analysis using surgically resected hepatocellular carcinoma (HCC) and adjacent non-tumorous liver tissues. We identified four cDNA fragments upregulated in HCC samples, encoding antisecretory factor-1 (AF), gp96, DAD1 and CDC34. Northern blot analysis demonstrated that these mRNAs were expressed preferentially in HCCs compared with adjacent non-tumorous liver tissues or normal liver tissues from non-HCC patients. The expression of these mRNAs was increased along with the histological grading of HCC tissues. These mRNA levels were also high in three human HCC cell lines (HuH-7, HepG2 and HLF), irrespective of the growth state. We also demonstrate that sodium butyrate, an inducer of differentiation, downregulated the expression of AF and gp96 mRNAs, supporting in part our pathological observation. Immunohistochemical analysis revealed that gp96 and CDC34 proteins were preferentially accumulated in cytoplasm and nuclei of HCC cells, respectively. Overexpression of these genes could be an important manifestation of HCC phenotypes and should provide clues to understand the molecular basis of hepatocellular carcinogenesis.
authors.affiliation: Department of Microbiology and Molecular Virology, School of Medicine, Tokyo Medical and Dental University, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Tanaka
authors.forename: N
authors.initials: N
authors.lastname: Kondoh
authors.forename: M
authors.initials: M
authors.lastname: Shuda
authors.forename: O
authors.initials: O
authors.lastname: Matsubara
authors.forename: N
authors.initials: N
authors.lastname: Imazeki
authors.forename: A
authors.initials: A
authors.lastname: Ryo
authors.forename: T
authors.initials: T
authors.lastname: Wakatsuki
authors.forename: A
authors.initials: A
authors.lastname: Hada
authors.forename: N
authors.initials: N
authors.lastname: Goseki
authors.forename: T
authors.initials: T
authors.lastname: Igari
authors.forename: K
authors.initials: K
authors.lastname: Hatsuse
authors.forename: T
authors.initials: T
authors.lastname: Aihara
authors.forename: S
authors.initials: S
authors.lastname: Horiuchi
authors.forename: N
authors.initials: N
authors.lastname: Yamamoto
authors.forename: M
authors.initials: M
authors.lastname: Yamamoto
mesh_terms: D000328:Adult; D000368:Aged; D064173:Anaphase-Promoting Complex-Cyclosome; D000951:Antigens, Neoplasm / Q000235:genetics* / Q000378:metabolism; D051017:Apoptosis Regulatory Proteins; D015152:Blotting, Northern; D006528:Carcinoma, Hepatocellular / Q000235:genetics* / Q000473:pathology; D018076:DNA, Complementary / Q000302:isolation & purification; D018450:Disease Progression; D005260:Female; D005819:Genetic Markers; D006801:Humans; D007150:Immunohistochemistry; D008025:Ligases / Q000235:genetics* / Q000378:metabolism; D008113:Liver Neoplasms / Q000235:genetics* / Q000473:pathology; D008297:Male; D008565:Membrane Proteins / Q000235:genetics* / Q000378:metabolism; D008875:Middle Aged; D012333:RNA, Messenger / Q000032:analysis / Q000378:metabolism*; D014407:Tumor Cells, Cultured; D044763:Ubiquitin-Conjugating Enzymes; D043743:Ubiquitin-Protein Ligase Complexes; D044767:Ubiquitin-Protein Ligases; D015854:Up-Regulation
chemical_list: D000951:Antigens, Neoplasm; D051017:Apoptosis Regulatory Proteins; C083331:DAD1 protein, human; D018076:DNA, Complementary; D005819:Genetic Markers; D008565:Membrane Proteins; D012333:RNA, Messenger; C052646:sarcoma glycoprotein gp96 rejection antigens; C577447:CDC34 protein, human; D044763:Ubiquitin-Conjugating Enzymes; D043743:Ubiquitin-Protein Ligase Complexes; D064173:Anaphase-Promoting Complex-Cyclosome; D044767:Ubiquitin-Protein Ligases; D008025:Ligases